MMR Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Response to ICIs in MMR-Deficient Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal Cancer
Oncologist 2021 Feb 25;[EPub Ahead of Print], IH Sahin, S Goyal, Y Pumpalova, MB Sonbol, S Das, S Haraldsdottir, D Ahn, KK Ciombor, Z Chen, A Draper, J Berlin, T Bekaii-Saab, GB Lesinski, BF El-Rayes, C WuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.